Medford (541) 770-2020

Grants Pass (541) 956-2020

Email Us

Patient Portal

Clinical Trials

Dedicated to Research

We strive to deliver the highest level of care for all retina-related eye conditions. Oregon Retina Center in Medford & Grants Pass is dedicated to providing clinical trials to our patients.

Oregon Retina Center research team

Clinical Trials

Nonvascular Age-related Macular Degeneration (Wet AMD)

Chengdu Kanghong “Panda2” (Currently Enrolling)
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration.

Geographic Atrophy (Dry AMD)

Apellis “DERBY” (Enrollment Coming Soon)
A Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Non-proliferative Diabetic Retinopathy

Regeneron PANORAMA (Enrollment No Longer Open)
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Phase 3 Study. This study will assess the efficacy of intravitreal aflibercept (Eylea) in participants with moderately severe to severe nonproliferative diabetic retinopathy.

Retinal Vein Occlusion

Clearside “SAPPHIRE” (Closed) 
Study of the safety and efficacy of Suprachoroidal CLS-TA in conjunction with intravitreal aflibercept (Eylea) in the treatment of retinal vein occlusion.
Phase 3 Study. This study will evaluate the combination of Suprachoroidal CLS-TA and Eylea in improving best-corrected visual acuity in patients with retinal vein occlusion.

Age-Related Macular Degeneration Research

Roche “AVENUE” (Closed)
A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD). Phase 2 Study. This study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of RG7716 in participants with subfoveal CNV secondary to AMD.

Diabetic Macular Edema (DME)

Clearside “TYBEE” (Closed)
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA with Intravitreal Aflibercept versus Aflibercept alone in Subjects with Diabetic Macular Edema.

Call us to learn more, (541) 770-2020.

Oregon Retina Center


1518 E Barnett Rd
Medford, OR 97504

(541) 770-2020


Write us a review

Grants Pass

1867 Williams Hwy
Grants Pass, OR 97527

(541) 956-2020


Write us a review


Monday, Tuesday, Wednesday, & Friday: 7:45 AM - 6:00 PM

Thursday: 7:45 AM - 5:00 PM

Oregon Retina Center in Medford & Grants Pass, OR

Proudly Serving Southern Oregon Communities

Jackson, Josephine, The Applegates, Ashland, Butte Falls, Central Point, Cave Junction, Eagle Point, Grants Pass, Jacksonville, Lake Creek, Medford, Merlin, Murphy, Phoenix, Prospect, Provolt, Rogue River, Ruch, Sams Valley, Shady Cove, Sunny Valley, Talent, Trail, White City, Williams, Wolf Creek